ERYN THOMAS: Open Payments
NPI 1467207183 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,384 in 59 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $683 · 2025 $1,384
Food & beverage: $1,384
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 22 | $443 |
| AstraZeneca Pharmaceuticals LP | 12 | $270 |
| Verona Pharma, Inc. | 5 | $208 |
| GENZYME CORPORATION | 6 | $166 |
| Regeneron Healthcare Solutions, Inc. | 5 | $98 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $56 |
| Novo Nordisk Inc | 2 | $40 |
| Fisher & Paykel Healthcare Inc | 1 | $26 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $20 |
Products named: NUCALA, DUPIXENT, Ohtuvayre, TEZSPIRE, TRELEGY ELLIPTA, BREZTRI, AIRSUPRA, Wegovy.
Industry payments across PA — which companies pay providers there.
